Harel Insurance Investments & Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $152K | Sell |
1,200
-1,049
| -47% | -$138K | ﹤0.01% | 360 |
|
|
2026
Q1 | $313K | Buy |
+2,249
| New | +$315K | ﹤0.01% | 257 |
|
|
2025
Q4 | – | Sell |
-2,461
| Closed | -$273K | – | 441 |
|
|
2025
Q3 | $273K | Sell |
2,461
-2,786
| -53% | -$317K | ﹤0.01% | 270 |
|
|
2025
Q2 | $582K | Buy |
5,247
+1,276
| +32% | +$136K | 0.01% | 211 |
|
|
2025
Q1 | $445K | Buy |
+3,971
| New | +$410K | 0.01% | 211 |
|
|
2024
Q3 | – | Sell |
-584
| Closed | -$40K | – | 522 |
|
|
2024
Q2 | $40K | Sell |
584
-57
| -9% | -$3.8K | ﹤0.01% | 390 |
|
|
2024
Q1 | $47K | Hold |
641
| – | – | ﹤0.01% | 375 |
|
|
2023
Q4 | $52K | Sell |
641
-3
| -0.5% | -$233 | ﹤0.01% | 416 |
|
|
2023
Q3 | $48K | Sell |
644
-17,634
| -96% | -$1.36M | ﹤0.01% | 467 |
|
|
2023
Q2 | $1.39M | Sell |
18,278
-14,402
| -44% | -$1.15M | 0.03% | 121 |
|
|
2023
Q1 | $2.66M | Buy |
32,680
+4,148
| +15% | +$344K | 0.05% | 124 |
|
|
2022
Q4 | $2.43M | Buy |
28,532
+7,332
| +35% | +$581K | 0.05% | 119 |
|
|
2022
Q3 | $1.34M | Buy |
21,200
+2,000
| +10% | +$126K | 0.03% | 153 |
|
|
2022
Q2 | $1.19M | Buy |
19,200
+19,020
| +10,567% | +$1.18M | 0.03% | 171 |
|
|
2022
Q1 | $11K | Buy |
180
+95
| +112% | +$6.07K | ﹤0.01% | 659 |
|
|
2021
Q4 | $6K | Sell |
85
-5,323
| -98% | -$367K | ﹤0.01% | 695 |
|
|
2021
Q3 | $378K | Buy |
5,408
+2,542
| +89% | +$179K | 0.01% | 265 |
|
|
2021
Q2 | $643K | Sell |
2,866
-1,298
| -31% | -$86.7K | 0.01% | 402 |
|
|
2021
Q1 | $899K | Sell |
4,164
-4,593
| -52% | -$296K | 0.02% | 383 |
|
|
2020
Q4 | $1.64M | Sell |
8,757
-7,993
| -48% | -$482K | 0.04% | 216 |
|
|
2020
Q3 | $1.06M | Buy |
16,750
+15,546
| +1,291% | +$1.08M | 0.04% | 117 |
|
|
2020
Q2 | $93K | Sell |
1,204
-8,946
| -88% | -$686K | ﹤0.01% | 336 |
|
|
2020
Q1 | $759K | Buy |
10,150
+10,106
| +22,968% | +$698K | 0.04% | 86 |
|
|
2019
Q4 | $3K | Sell |
44
-7,256
| -99% | -$473K | ﹤0.01% | 452 |
|
|
2019
Q3 | $463K | Buy |
7,300
+2,900
| +66% | +$190K | 0.03% | 119 |
|
|
2019
Q2 | $297K | Buy |
4,400
+1,200
| +38% | +$78.9K | 0.02% | 162 |
|
|
2019
Q1 | $208K | Sell |
3,200
-814
| -20% | -$54.1K | 0.01% | 122 |
|
|
2018
Q4 | $251K | Sell |
4,014
-2,121
| -35% | -$148K | 0.02% | 158 |
|
|
2018
Q3 | $474K | Sell |
6,135
-7,865
| -56% | -$594K | 0.02% | 143 |
|
|
2018
Q2 | $992K | Buy |
14,000
+2,000
| +17% | +$141K | 0.05% | 92 |
|
|
2018
Q1 | $905K | Buy |
12,000
+6,952
| +138% | +$553K | 0.05% | 106 |
|
|
2017
Q4 | $362K | Buy |
5,048
+28
| +0.6% | +$2.13K | 0.02% | 162 |
|
|
2017
Q3 | $407K | Buy |
5,020
+2,900
| +137% | +$222K | 0.03% | 107 |
|
|
2017
Q2 | $150K | Buy |
2,120
+480
| +29% | +$31.9K | 0.01% | 211 |
|
|
2017
Q1 | $110K | Buy |
1,640
+1,400
| +583% | +$98.4K | 0.01% | 205 |
|
|
2016
Q4 | $17K | Buy |
+240
| New | +$17.8K | ﹤0.01% | 264 |
|
|
2016
Q3 | – | Sell |
-4,100
| Closed | -$342K | – | 553 |
|
|
2016
Q2 | $342K | Buy |
+4,100
| New | +$364K | 0.04% | 110 |
|
Other funds holding GILD
Harel Insurance Investments & Financial Services's GILD Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services reduced its Gilead Sciences (GILD) stake by 47% in Q2 2026, selling an estimated $138K and leaving 1,200 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #360.
Harel Insurance Investments & Financial Services first reported a position in GILD in Q2 2016 and has held it in 37 quarters since. The position peaked at $2.66M in Q1 2023. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Harel Insurance Investments & Financial Services held 1,200 shares of Gilead Sciences worth $152K as of Q2 2026.
- Harel Insurance Investments & Financial Services sold 1,049 Gilead Sciences shares in Q2 2026, an estimated $138K.
- Gilead Sciences made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #360 holding.
- Harel Insurance Investments & Financial Services first reported a position in Gilead Sciences in Q2 2016 and has held it in 37 quarters since.
- Harel Insurance Investments & Financial Services's Gilead Sciences position peaked at $2.66M in Q1 2023.
- 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.